Epilepsy care in developing countries: part I of II

Area of Science:

• Neurology
• Global Health
• Public Health

Background:

• Epilepsy disproportionately affects individuals in low-resource, developing nations, with up to 80% of patients residing in these areas.
• A significant treatment gap exists, leaving the majority of epilepsy patients in these regions without adequate care.
• Current epilepsy management strategies in developing countries are often insufficient to meet the population's needs.

Purpose of the Study:

• To review the global burden of epilepsy, particularly in resource-poor settings.
• To assess the current state of epilepsy treatment resources in developing countries.
• To highlight the need for accessible, sustainable epilepsy care models.

Main Methods:

• Review of existing literature and data on epilepsy prevalence and treatment in developing countries.
• Analysis of the challenges and limitations in current healthcare systems for epilepsy management.
• Identification of key factors contributing to the treatment gap.

Main Results:

• The majority of the global epilepsy population lives in developing countries, facing limited access to care.
• Significant disparities in treatment availability and quality exist between high-income and low-income countries.
• Existing primary healthcare infrastructures are underutilized for epilepsy management.

Conclusions:

• There is an urgent need for cost-effective and sustainable epilepsy care services in developing countries.
• Integrating first-line antiepileptic drug delivery into primary healthcare facilities is essential.
• The involvement of neurologists with local cultural understanding is vital for education, policy, and advocacy to improve epilepsy care.